Skip to main content

Find Clinical Trials

Home
Conditions
Blood Protein Disorders

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,042 public trials 567 recruiting studies

Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma

NCT01057225

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

Medical University of South Carolina Charleston, South Carolina, United States

View Trial Details

Completed

FREE Study - Fracture Reduction Evaluation

NCT00211211

Conditions: Back Pain, Blood Protein Disorders, Bone Diseases, +26 more
Locations: University of Alabama Birmingham, Alabama, United States

View Trial Details

Completed

Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma

NCT00258206

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Total Marrow Irradiation for Refractory Acute Leukemia

NCT00686556

Conditions: Acute Lymphoblastic Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +24 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen

NCT00556452

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +22 more
Locations: University of Michigan, Department of Internal Medicine, Blood and Marrow Transplant Program Ann Arbor, Michigan, United States

View Trial Details

Completed

A Study to Collect and Evaluate the Safety and Efficacy Information of Korean Multiple Myeloma Patients Treated With REVLIMID®, After Approval of Marketing Authorization for New Drug in Korea

NCT02556905

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Hallym University Sacred Heart Hospital Anyang, South Korea

Soon Chun Hyang University Hospital Bucheon Bucheon-si, South Korea

Inje University Busan Paik Hospital Busan, South Korea

Inje University Haeundae Paik Hospital Busan, South Korea

View all 25 locations

View Trial Details

Completed

T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer

NCT00602693

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +37 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma

NCT00889408

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +48 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States

Scott and White Cancer Institute Temple, Texas, United States

View Trial Details

Completed

Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant

NCT00530218

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +21 more
Locations: City of Hope National Medical Center Duarte, California, United States

View Trial Details

Completed

Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma

NCT02406144

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Complejo Hospitalario Universitario de Santiago A Coruña, Spain

Hospital Txagorritxu Alava, Spain

Hospital General de Albacete Albacete, Spain

Hospital Del Vinalopo Alicante, Spain

View all 74 locations

View Trial Details